A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex ...

The study tested different methods of training healthcare providers so they could help their patients better manage chronic ...

Stefan Kertesz, a physician and addiction expert, says overaggressive cutbacks can harm some chronic pain patients.

Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation. A new report from the Centers for Disease Control ...

Objectives Analgesia and sedation are common therapies in pediatric critical care, and rapid titration of these medications is associated with iatrogenic withdrawal syndrome. We performed a ...

For the first time in two decades, the FDA has approved a new class of non-opioid pain medication, offering an alternative to addictive opioids for patients seeking pain relief. The drug ...

Despite years of official claims that it was “misinformation” to suggest that the black market was being flooded with ...

Washington — Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin.

New Monash University research has revealed a concerning rise in new opioid prescriptions among younger Victorians, while also finding an overall positive trend, with a drop in opioid prescription ...

Endo's slide into bankruptcy follows in the footsteps of Purdue Pharma – which filed in 2019 but is still negotiating opioid settlement and corporate restructuring terms – as well as ...